Navigation Links
Car Airbags Most Suited To Medium-Built Individuals

t risk" from air bags, says the NHTSA. "The primary determinant as to whether an individual will be injured by a deploying air bag is the distance from which the individual is seated from the air bag."

The NHTSA notes that there is also no precise distance guaranteed to avoid air bag injury since all air bags are unique and deploy with different forces.

The NHTSA's advice included the following: * Wear your seatbelt. * Sit as far from the air bag as possible to allow the air bag to deploy. * Short drivers should move the driver's seat back and tilt the seat back slightly to allow space between the driver's chest and the steering wheel. * Drivers should refrain from leaning forward. * to the extent possible, drivers should hold steering wheels from the side, so that their arms aren't in the way of the air bag.

Says Newgard: "There's been a lot of interest in airbags for the last 10 to 15 years.

"Airbags are designed to be a protective mechanism for automobiles but as the years have gone on and we've gained more insight we know that certain groups of people are at risk of injury rather than have a benefit from them."

"That's pretty well established in kids and there have been some small case reports to suggest that maybe small stature adults are also at risk but it's never really been demonstrated conclusively," Newgards adds.

Yet, Newgard says, "From the study, both small-stature and large-stature occupants look to be at increased risk of injury from the airbag rather than having a benefit."


'"/>




Page: 1 2

Related medicine news :

1. Airbags lessens oppressive eye injuries
2. Car Airbags Will Cause Permanent Hearing Loss in 17 Percent
3. Humans Genetically More Suited To Being Vegetarians Than Meat-eaters
4. Individuals with sleep related breathing disorders more prone to heart disease
5. Excess Weight Can Affect Individuals as They Age
6. Hypnosis Can Help Individuals Quit Smoking
7. Good News For Individuals Suffering From Frequent Throat Infections
8. Drug Found To Bring Relief For Individuals With Early Parkinson’
9. Individuals With Metabolic Syndrome At Risk of Dying From Heart Disease
10. Common Infections Found To Raise An Individuals Risk Of Having A Heart Attack Or Stroke
11. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
Post Your Comments:
(Date:10/7/2008)... WASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -...ight for the second presidential debate, Jean,Berg...e Florida, will be in,the audience, waiting to ask...ts and make it harder for families to afford cover...y 28 years and has never had,healthcare., "It,s t...
(Date:10/7/2008)... Compression ultrasound similar to more expensive... , TUESDAY, Oct. 7 (HealthDay News) -- An o...leg -- called deep vein thrombosis, or DVT -- is a...esearch says. , European researchers found that...alled compression or duplex ultrasound -- was as g...
(Date:10/7/2008)... SEDONA, Ariz., Oct. 7 /PRNewswire/ -- Join M...or a four-day celebration in Sedona,s red rock,cou...Activities include a,series of traditional Native ... Program Director R.J. Joseph and special guest, E...espected Blackfoot Elder from the Blood Reserve,in...
(Date:10/7/2008)... MORE THAN 100,000 PEOPLE ACROSS THE NATION H... CURE(R), DALLAS, Oct. 7 /PRNewswire/ -- To...d all voters about the positions of presidential c... key health care and cancer issues,the Susan G. K...led a,series of resources available on its web sit...
Breaking Medicine News(10 mins):Health News:SEIU Member Will Be in Town Hall Audience, Ready to Ask John McCain Why He Won't Provide Affordable Healthcare for All 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3
...l toxins in corn may be the reason for neural tube...the early 1990's. The study published in the on ...gests that corn and its products //that have been ...ht give rise to neural tube defects (NTD), if cons...
...ng is reportedly being prohibited on the grounds o...on a vacation at Utah. The British Medical Journal...second hand smoke (SHS) does not raise the risk //... the measures as attempts by the powerful antismok...
...h officials in Argentina have reported an outbreak...der close to Paraguay. More than 70 cattle have be... province, //according to reports by National Serv... origin of the outbreak is yet to be identified an...
...an Letter, a male nurse aged 27, has admitted to k...hat nothing of what he says could actually justify...eat compassion to alleviate their pain.// He was ...urders to manslaughter, to reduce the penalty. The...
Other Medicine News:Health News:Fungal toxins infected corn the reason for congenital defects 2
(Date:10/7/2008)...of FLEXX Trial Presented at the Osteoarthritis Res... PARSIPPANY, N.J., Oct. 7 /- Ferring...rom the FLEXX Trial of Osteoarthritis of the,Knee,... a highly pure,non-avian high molecular weight for...uperior to intra-articular saline (IA-saline) for ...
(Date:10/7/2008)...nical study of adults, VYVANSE taken once-daily si...ne week, PHILADELPHIA, Oct. 7 /PRNewswire-FirstCa...obal specialty biopharmaceutical company, today,an...sue of the Journal of,Clinical Psychiatry found on...Deficit Hyperactivity Disorder (ADHD) symptoms in ...
(Date:10/7/2008)..., Calif., Oct. 7 /- Aerovance Inc. to...from a Phase I trial of its Aerovant,inhalation po...idence of,local irritancy following asthma patient... dose will be the highest of three doses investiga...hich is scheduled to begin early,next year. Eviden...
(Date:10/7/2008)...5 Patient Cohort Enrolled in Stage A of Trial Asse...h Carboplatin and Paclitaxel -, TUSTIN, Calif., O...uticals, Inc. (Nasdaq: PPHM ), a clinical stage b...ibodies for the treatment of cancer and,hepatitis ...as completed,enrollment in the first stage of a Ph...
Breaking Medicine Technology:Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Young Pop Stars Emphysema Startles Experts 22570 1Young Pop Stars Emphysema Startles Experts 22570 2Young Pop Stars Emphysema Startles Experts 22570 3Studies Show USGI Medicals EndoSurgical Operating System 28TM 29 Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass 6162 1Studies Show USGI Medicals EndoSurgical Operating System 28TM 29 Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass 6162 2Arterial Calcium Scans Can Predict Death Risk 22563 1Arterial Calcium Scans Can Predict Death Risk 22563 2Arterial Calcium Scans Can Predict Death Risk 22563 3Arterial Calcium Scans Can Predict Death Risk 22563 4Advertising Hall of Famer Charles D Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy 22559 1Advertising Hall of Famer Charles D Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy 22559 2
...LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - Intro...ted ADVEXIN(R) biomarker data over,the weekend in ...he,American Association for Cancer Research., Abno...most,common and fundamental molecular defects in c...o restoring p53 tumor suppressor,function and the ...
...- As previously announced, primary endpoint not me...t-study treatment with ERBITUX,-, NEW YORK, April ... Incorporated and Bristol-Myers Squibb Company tod...- a randomized,open-label, multi-center Phase III...notecan to irinotecan alone in patients with,metas...
Other Medicine Technology:Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 2Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 3Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant.
Intermittent catheter
Intermittent catheter
Medicine Products: